C2 Pharma (C2P), a pharmaceutical group established in 2014 focused on niche active pharmaceutical ingredient (APIs), has expanded its portfolio of APIs and botanical extracts throughout 2020 and will continue pursuing the expansion into 2021. Multiple regulatory filings have been submitted to expand distribution channels globally across China, Taiwan, South Korea, Brazil, and Mexico.   “Since announcing our intentions to go through a growth spurt at CPhI Worldwide in 2019 we have been actively ...